» Articles » PMID: 19481034

Feline Herpesvirus Infection. ABCD Guidelines on Prevention and Management

Abstract

Overview: Feline viral rhinotracheitis, caused by feline herpesvirus (FHV), is an upper respiratory tract disease that is often associated with feline calicivirus and bacteria. In most cats, FHV remains latent after recovery, and they become lifelong virus carriers. Stress or corticosteroid treatment may lead to virus reactivation and shedding in oronasal and conjunctival secretions.

Infection: Sick cats shed FHV in oral, nasal and conjunctival secretions; shedding may last for 3 weeks. Infection requires direct contact with a shedding cat.

Disease Signs: Feline herpesvirus infections cause acute rhinitis and conjunctivitis, usually accompanied by fever, depression and anorexia. Affected cats may also develop typical ulcerative, dendritic keratitis.

Diagnosis: Samples consist of conjunctival, corneal or oropharyngeal swabs, corneal scrapings or biopsies. It is not recommended that cats recently vaccinated with a modified-live virus vaccine are sampled. Positive PCR results should be interpreted with caution, as they may be produced by low-level shedding or viral latency.

Disease Management: 'Tender loving care' from the owner, supportive therapy and good nursing are essential. Anorexic cats should be fed blended, highly palatable food - warmed up if required. Mucolytic drugs (eg, bromhexine) or nebulisation with saline may offer relief. Broad-spectrum antibiotics should be given to prevent secondary bacterial infections. Topical antiviral drugs may be used for the treatment of acute FHV ocular disease. The virus is labile and susceptible to most disinfectants, antiseptics and detergents.

Vaccination Recommendations: Two injections, at 9 and 12 weeks of age, are recommended, with a first booster 1 year later. Boosters should be given annually to at-risk cats. For cats in low-risk situations (eg, indoor-only cats), 3-yearly intervals suffice. Cats that have recovered from FHV-associated disease are usually not protected for life against further disease episodes; vaccination of recovered cats is therefore recommended.

Citing Articles

Recent Issues in the Development and Application of Targeted Therapies with Respect to Individual Animal Variability.

Kurhaluk N, Tkaczenko H Animals (Basel). 2025; 15(3).

PMID: 39943214 PMC: 11815764. DOI: 10.3390/ani15030444.


Development of a reporter feline herpesvirus-1 for antiviral screening assays.

Yang J, Li L, Xu F, Jia F Vet Res. 2024; 55(1):167.

PMID: 39696698 PMC: 11654381. DOI: 10.1186/s13567-024-01430-7.


Antiviral Activity of Nitazoxanide and Miltefosine Against FeHV-1 In Vitro.

Longobardi C, Ferrara G, Damiano S, Florio S, Iovane G, Pagnini U Vet Med Int. 2024; 2024:8849561.

PMID: 39464309 PMC: 11512641. DOI: 10.1155/2024/8849561.


The Latest Prevalence, Isolation, and Molecular Characteristics of Feline Herpesvirus Type 1 in Yanji City, China.

Yang M, Mu B, Ma H, Xue H, Song Y, Zhu K Vet Sci. 2024; 11(9).

PMID: 39330796 PMC: 11435738. DOI: 10.3390/vetsci11090417.


Feline respiratory disease complex: insights into the role of viral and bacterial co-infections.

Maboni G, Che S, Tallmadge R, De Luca E, Goodman L, Weese J Front Microbiol. 2024; 15:1455453.

PMID: 39290513 PMC: 11405337. DOI: 10.3389/fmicb.2024.1455453.


References
1.
Maggs D . Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clin Tech Small Anim Pract. 2005; 20(2):94-101. DOI: 10.1053/j.ctsap.2004.12.013. View

2.
Pedersen N, Sato R, Foley J, Poland A . Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus. J Feline Med Surg. 2004; 6(2):83-8. PMC: 7128562. DOI: 10.1016/j.jfms.2003.08.008. View

3.
Binns S, Dawson S, Speakman A, Cuevas L, Hart C, Gaskell C . A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. J Feline Med Surg. 2001; 2(3):123-33. PMC: 10829116. DOI: 10.1053/jfms.2000.0084. View

4.
Storey E, Gerding P, Scherba G, Schaeffer D . Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions. Vet Ophthalmol. 2002; 5(4):263-7. DOI: 10.1046/j.1463-5224.2002.00234.x. View

5.
Mouzin D, Lorenzen M, Haworth J, King V . Duration of serologic response to three viral antigens in cats. J Am Vet Med Assoc. 2004; 224(1):61-6. DOI: 10.2460/javma.2004.224.61. View